Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA schedules advisory committee meeting on communications

This article was originally published in The Tan Sheet

Executive Summary

The Risk Communication Advisory Committee will discuss developments in FDA's ongoing communications programs at public meeting Nov. 8-9 in Silver Spring, Md. Potential discussion topics include FDA's Strategic Plan for Risk Communication, FDA's Transparency Initiative and "the challenges of effectively communicating with patients and caregivers about appropriate use of medical devices when a patient is prescribed a medical device for home use," according to a Sept. 20 Federal Register notice. FDA will accept requests to make oral presentations through Oct. 21 and written submissions through Oct. 29
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS104513

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel